JSC Farmak (Ukrainian: Фармак) is the Ukrainian pharmaceutical market leader based on the sales of medicinal products in monetary terms (according to Proxima Research in 2022).[1] The company has been established in 1925. The headquarters is located in Kyiv, Ukraine. The chairman of the supervisory board is Filya Zhebrovska, sister of Pavlo Zhebrivskyi. The Chief Executive Officer is Volodymyr Kostiuk.
The company manufactures over 400 medicinal products. They are presented in 14 therapeutic groups. The portfolio mainly consists of anti-cold, endocrinological, gastroenterological, cardiological and neurological products.
The products manufactured by JSC Farmak are exported to more than 40 countries. Farmak's medicinal products are marketed in the countries of the EU, Central and South America, the CIS, the Middle East, Asia. The company has five international representative offices in Uzbekistan, Kazakhstan, Kyrgyzstan, Poland, Vietnam, as well as an office in the UAE.[2]